BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 15858066)

  • 1. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
    Hurst RS; Hajós M; Raggenbass M; Wall TM; Higdon NR; Lawson JA; Rutherford-Root KL; Berkenpas MB; Hoffmann WE; Piotrowski DW; Groppi VE; Allaman G; Ogier R; Bertrand S; Bertrand D; Arneric SP
    J Neurosci; 2005 Apr; 25(17):4396-405. PubMed ID: 15858066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
    Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
    Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An allosteric modulator of alpha7 nicotinic receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), causes conformational changes in the extracellular ligand binding domain similar to those caused by acetylcholine.
    Barron SC; McLaughlin JT; See JA; Richards VL; Rosenberg RL
    Mol Pharmacol; 2009 Aug; 76(2):253-63. PubMed ID: 19411608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596.
    Kalappa BI; Gusev AG; Uteshev VV
    PLoS One; 2010 Nov; 5(11):e13964. PubMed ID: 21103043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological concentrations of choline activate native alpha7-containing nicotinic acetylcholine receptors in the presence of PNU-120596 [1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)-urea].
    Gusev AG; Uteshev VV
    J Pharmacol Exp Ther; 2010 Feb; 332(2):588-98. PubMed ID: 19923442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases.
    Charpantier E; Wiesner A; Huh KH; Ogier R; Hoda JC; Allaman G; Raggenbass M; Feuerbach D; Bertrand D; Fuhrer C
    J Neurosci; 2005 Oct; 25(43):9836-49. PubMed ID: 16251431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneurons.
    Lopez-Hernandez G; Placzek AN; Thinschmidt JS; Lestage P; Trocme-Thibierge C; Morain P; Papke RL
    Neuropharmacology; 2007 Jul; 53(1):134-44. PubMed ID: 17544457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.
    Kalappa BI; Sun F; Johnson SR; Jin K; Uteshev VV
    Br J Pharmacol; 2013 Aug; 169(8):1862-78. PubMed ID: 23713819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
    Collins T; Young GT; Millar NS
    Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.
    Hajós M; Hurst RS; Hoffmann WE; Krause M; Wall TM; Higdon NR; Groppi VE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1213-22. PubMed ID: 15523001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.
    Malysz J; Grønlien JH; Anderson DJ; Håkerud M; Thorin-Hagene K; Ween H; Wetterstrand C; Briggs CA; Faghih R; Bunnelle WH; Gopalakrishnan M
    J Pharmacol Exp Ther; 2009 Jul; 330(1):257-67. PubMed ID: 19389923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PNU-120596, a positive allosteric modulator of mammalian α7 nicotinic acetylcholine receptor, is a negative modulator of ligand-gated chloride-selective channels of the gastropod Lymnaea stagnalis.
    Vulfius CA; Lebedev DS; Kryukova EV; Kudryavtsev DS; Kolbaev SN; Utkin YN; Tsetlin VI
    J Neurochem; 2020 Nov; 155(3):274-284. PubMed ID: 32248535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795.
    López-Hernández GY; Thinschmidt JS; Morain P; Trocme-Thibierge C; Kem WR; Soti F; Papke RL
    Neuropharmacology; 2009 Mar; 56(4):821-30. PubMed ID: 19705574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
    J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic integration of single ion channel responses of α7 nicotinic acetylcholine receptors enhanced by PNU-120596.
    Uteshev VV
    PLoS One; 2012; 7(3):e32951. PubMed ID: 22479351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic properties and open probability of α7 nicotinic acetylcholine receptors.
    Pesti K; Szabo AK; Mike A; Vizi ES
    Neuropharmacology; 2014 Jun; 81():101-15. PubMed ID: 24486379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive allosteric modulators of the α7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596.
    Acker BA; Badescu VO; Berkenpas MB; Groppi VE; Hajós M; Higdon NR; Hurst RS; Jon Jacobsen E; Margolis BJ; McWhorter WW; Myers JK; Piotrowski DW; Rogers BN; Sarapa D; Vetman TN; Walker DP; Wall TM; Wilhite DM; Wishka DG; Xu W; Yates KM
    Bioorg Med Chem Lett; 2023 Sep; 93():129433. PubMed ID: 37557923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.
    Peng C; Kimbrell MR; Tian C; Pack TF; Crooks PA; Fifer EK; Papke RL
    Mol Pharmacol; 2013 Sep; 84(3):459-75. PubMed ID: 23839567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
    Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
    J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.